The toolkit provides physicians and patients with resources to encourage communication and decision-making to help reduce patients' postoperative pain as much and as safely as possible.
Chronic low back pain is highly prevalent in US adults and is a major cause of missed work days and disability. While several treatment options exist, chronic opioids are commonly used for these conditions even though there are limited data supporting efficacy, and clear evidence of harm associated with chronic opioid administration.
The ageing global population and concomitant increase in the use of opioid analgesia have highlighted the need to evaluate the effectiveness of opioids for chronic pain in older people.
The opioid crisis is partly due to opioids prescribed after elective surgery. This study sought to determine if a preemptive pain-management program would be associated with opioid-free discharge after benign foregut surgery.
The newly published report describes characteristics of visits to office-based physicians at which benzodiazepines were prescribed, including visits where opioids were coprescribed.
The goal of this study is to evaluate the analgesic efficacy of bilateral erector spinae plane (ESP) blocks after lumbar and lumbo-sacral spine surgery by assessing postoperative pain scores and opiate requirements as the primary outcome measures.
Opioid use among psychiatric hospital patients needs to be addressed through an integrated approach to managing mental illness, pain and substance use, a study by researchers at the University of Waterloo has found.
AAPM member Beth Hogans, MD PhD, served as a panelist on the University of Maryland Center to Advance Chronic Pain Research annual symposium, "Managing Chronic Pain Among Patients with Serious Illness During a National Opioid Crisis."
Despite the large comorbidity between PTSD and opioid use disorders, as well as the common treatment of physical injuries resulting from trauma with opioids, the ability of opioid treatments to subsequently modify PTSD-related behavior has not been well studied.
Prescriptions for nonopioid pharmacological therapies such as gabapentin and baclofen have been increasing. While gabapentin and baclofen are less likely than opioids to result in fatal overdose, they are each associated with dependence, misuse and adverse effects.
A West Virginia University researcher is investigating whether an anti-itch medication that targets a specific part of our nerve cells can make morphine—which targets a different part—more effective.
The U.S. Department of Health and Human Services (HHS) announced more than $1.8 billion in funding to states to continue the Trump administration's efforts to combat the opioid crisis by expanding access to treatment and supporting near real-time data on the drug overdose crisis.
Despite known risks of using chronic opioid therapy (COT) for pain, the risks of discontinuation of COT are largely uncharacterized. The objective of this study was to evaluate mortality, prescription opioid use, and primary care utilization of patients discontinued from COT, compared with patients maintained on opioids.
AAPM Secretary W. Michael Hooten, MD comments on a new study on opioid and cannabis co-use, pointing out that the study shows us "that individuals with chronic pain who use opioids and cannabis concurrently are more likely to have mental health problems and other substance use issues, and that is very important." Dr. Hooten was not an author in the study.
AAPM member Beth B. Hogans, MD PhD comments in this NPR interview about the four-day course she helped create at Johns Hopkins for medical students about pain and pain management at the start of their medical education.
Using opioids for acute pain can lead to long-term use and associated morbidity and mortality. Injury has been documented as a gateway to long-term opioid use in some populations, but data are limited for injured workers.
A novel opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System is as strong as morphine but isn't addictive and causes fewer side effects, according to a new study published in the Journal of Neuroinflammation.
An Oregon committee has abandoned a controversial proposal that would have expanded treatment options for chronic pain patients under the Oregon Health Plan, but would have forced many to reduce dosages or discontinue prescription opioids.
The U.S. Food and Drug Administration (FDA) has received reports of serious harm in patients who are physically dependent on opioid pain medicines suddenly having these medicines discontinued or the dose rapidly decreased. These include serious withdrawal symptoms, uncontrolled pain, psychological distress, and suicide.
AAPM Past President Sean Mackey, MD PhD, co-authored a BMJ editorial on how the national pain strategies are part of the solution in managing this twin crises.